Search results
Results from the WOW.Com Content Network
Pages in category "Pharmaceutical companies of Indonesia" The following 6 pages are in this category, out of 6 total. This list may not reflect recent changes .
In 2014, IBA Group joined the International Association of Outsourcing Professionals (IAOP). [13] In 2015, IBA Group opened an office in Bratislava, Slovakia. [14] In 2017, IBA CZ moved to a new office in Prague. [15] In the same year, IBA Group opened a development center in Bulgaria. [16] In 2018, IBA Group joined the UN Global Compact ...
Location of Indonesia. Indonesia is a unitary sovereign state and transcontinental country located mainly in Southeast Asia with some territories in Oceania. Indonesia's economy is the world's 16th largest by nominal GDP and the 8th largest by GDP at PPP, the largest in Southeast Asia, and is considered an emerging market and newly industrialised country.
This table reflects the Forbes Global 2000 list, which ranks the world's 2,000 largest publicly traded companies. "The Global 2000" list is assembled based on factors including revenue, net profit, total assets and market value; each element is assigned a weighted rank in terms of importance when assessing the overall ranking.
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. [1] The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Indonesian Food and Drug Authority (Indonesian: Badan Pengawas Obat dan Makanan, lit. 'Food and Drug Supervisory Agency'), Badan POM/BPOM, or Indonesian FDA is a government agency of Indonesia responsible for protecting public health through the control and supervision of prescription and over-the-counter pharmaceutical drugs (medication), vaccines, biopharmaceuticals, dietary supplements ...
IBA has developed an affinity chromatography system for non-magnetic isolation of peripheral blood mononuclear cells, T cells, B cells and other cells of interest. This technology is known as Fab-TACS (Traceless Affinity Cell Selection) and is based on Strep-tagged Fab fragments, which reversibly capture and release the target cells.
Its Indonesia operations comprise of PT Errita Pharma (Errita) and PT Millennium Pharmacon International Tbk (MPI). MPI is a public listed company on the Indonesia Stock Exchange with 35 branches nationwide. Meanwhile, Errita produces over 60 generic pharmaceuticals as well as over-the-counter products.